News and Announcements
Proteomics Non-Renounceable Entitlement Issue of Options
- Published September 14, 2015 2:49PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
11th September 2015, ASX Announcement
Dear Option Holder,
Proteomics International Laboratories Ltd (PIQ or the Company) is undertaking a pro-rata non-renounceable entitlement to shareholders of approximately 12,645,363 options (exercisable at $0.20 each and expiring 31 March 2018) at an issue price of $0.01 each (Options) to raise up to approximately $126,454 before costs (Entitlement Issue or Offer). The Offer is written by K S Capital Pty Limited (Underwriter). K S Capital Pty Lts is also lead manager under the Offer.
The Entitlement Issue will be offered to shareholders registered at the Entitlement Record Date (as defined below) with a registered address in Australia or New Zealand (Eligible Shareholders) on the basis of one (1) Option for every four (4) Shares held.
PIQ announces the Record Date of 5.oopm (AWST) on 18 September 2015 for the purposes of determining shareholders entitled to participate in the Entitlement to Issue (Entitlement Record Date). A prospectus containing full details of the Entitlement Issue was lodged with ASIC on 11 September 2015 and will be despatched to all Eligible Shareholders on 21 September 2015. the prospectus will be available on the ASX website (company announcements section, ASX code: PIQ)
To read the full announcement, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
